The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,640.50
Bid: 1,640.00
Ask: 1,640.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.03%)
Open: 1,642.00
High: 1,656.00
Low: 1,635.00
Prev. Close: 1,636.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

10 Jun 2022 09:33

GSK closer to cracking elusive vaccine for common respiratory virus

LONDON, June 10 (Reuters) - GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the vaccine was effective in a keenly-watched late-stage study involving older adults.

Read more
10 Jun 2022 08:57

LONDON MARKET OPEN: GSK rises as RSV vaccine succeeds in trial

(Alliance News) - Stock prices in London opened lower on Friday with trepidation ahead of US inflation data in the afternoon, while GSK bucked the market trend on upbeat late-stage trial results for a vaccine.

Read more
10 Jun 2022 08:14

TOP NEWS: GSK closer to first respiratory syncytial virus vaccine

(Alliance News) - Drugmaker GSK PLC on Friday said its vaccine candidate for respiratory syncytial virus, or RSV, showed positive phase three data in older adults.

Read more
10 Jun 2022 07:55

LONDON MARKET PRE-OPEN: GSK get positive RSV vaccine trial results

(Alliance News) - Equities in London are seen opening lower on Friday with investors cautious ahead of key US inflation data at 1330 BST.

Read more
10 Jun 2022 07:03

GSK says respiratory vaccine shows 'significant' efficacy in trial

(Sharecast News) - GlaxoSmithKline said its vaccine for respiratory virus had shown "statistically significant" and clinically meaningful efficacy in adults aged 60 years and above in a phase 3 trial.

Read more
6 Jun 2022 10:05

GSK wins FDA approval for measles, mumps and rubella vaccine Priorix

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has approved its Priorix vaccine for active immunisation for the prevention of measles, mumps and rubella in individuals of 12 months of age and older.

Read more
6 Jun 2022 07:57

GSK's MMR vaccine Priorix gets US FDA approval

(Sharecast News) - GlaxoSmithKline said on Monday that the US Food and Drug Administration has approved its Priorix vaccine for measles, mumps and rubella in people aged 12 months and older.

Read more
6 Jun 2022 07:46

LONDON MARKET PRE-OPEN: Melrose sells Ergotron for USD650 million

(Alliance News) - Stock prices in London are seen opening higher on Monday, following the long holiday weekend in the UK, tracking gains in Asian equity markets as Beijing further relaxed pandemic restrictions.

Read more
2 Jun 2022 11:39

Top-10 Unilever investor backs Peltz to bring urgency

FRANKFURT, June 2 (Reuters) - Germany's Flossbach von Storch, a top-10 shareholder in Unilever, is backing Nelson Peltz to bring urgency to the consumer goods giant, but doesn't expect major structural changes, it said on Thursday.

Read more
1 Jun 2022 17:06

LONDON MARKET CLOSE: No jubilee euphoria as inflation fears remain

(Alliance News) - Stocks in London ended lower on Wednesday ahead of the extra long Jubilee bank holiday weekend as investors weigh inflation and interest rates.

Read more
1 Jun 2022 15:59

Pfizer to sell stake in GSK's consumer health business after it lists

LONDON, June 1 (Reuters) - Pfizer plans to sell its 32% stake in Haleon, its consumer health venture with British drugmaker GSK, after the business lists as an independent company in July, GSK said on Wednesday.

Read more
1 Jun 2022 11:58

UPDATE: Pfizer to exit 32% stake in GSK consumer JV Haleon after float

(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon.

Read more
1 Jun 2022 09:05

TOP NEWS: GSK files plan for consumer arm demerger with UK regulator

(Alliance News) - GSK PLC on Wednesday said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon.

Read more
1 Jun 2022 08:48

Pfizer to exit GSK's consumer health arm after spin-off

LONDON, June 1 (Reuters) - Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with GSK , after the business is spun off as an independent company in July, GSK said on Wednesday.

Read more
1 Jun 2022 08:26

LONDON BRIEFING: Tullow Oil and Capricorn Energy set all-share merger

(Alliance News) - Tullow Oil and Capricorn Energy on Wednesday said they have agreed to an all-share merger.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.